Attitudes and Perceptions of Corresponding Authors From Top International Medical Journals Regarding the Use of Artificial Intelligence in the Scientific Process
AISurvey6 A+
1 other identifier
observational
500
1 country
1
Brief Summary
"Artificial intelligence (AI), including large language models and conversational tools, is increasingly being used in medical research. These tools may assist researchers at different stages of the scientific process, such as generating research ideas, reviewing the literature, analyzing data, writing manuscripts, and preparing articles for publication. While interest in AI is growing rapidly, there is still limited information on how these tools are actually perceived and used by leading medical researchers. This study aims to better understand the attitudes, perceptions, and self-reported uses of artificial intelligence among corresponding authors who have published in six major international medical journals. These authors play a key role in shaping scientific standards and editorial practices, and their views are essential to understanding how AI may influence the future of medical research. Participants are invited to complete an anonymous online questionnaire that asks about their familiarity with AI tools, how and when they use or plan to use them in the research process, the potential benefits they perceive, and the concerns or limitations they identify. The survey also explores participants' expectations regarding transparency, ethical guidance, and journal policies related to the use of artificial intelligence in scientific work.The study is observational and does not involve any medical intervention or collection of personal or health-related data. Participation is voluntary, and responses are fully anonymous.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2025
CompletedFirst Submitted
Initial submission to the registry
December 24, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedJanuary 8, 2026
December 1, 2025
3 months
December 24, 2025
December 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Self-reported attitudes regarding the use of artificial intelligence in the scientific research process
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
At the inclusion
Perceptions regarding the use of artificial intelligence in the scientific research process
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
At the inclusion
Secondary Outcomes (4)
Self-reported patterns of use, regarding artificial intelligence tools in scientific research and publishing
At the inclusion
Perceived benefits regarding artificial intelligence tools in scientific research and publishing
At the inclusion
Risk regarding artificial intelligence tools in scientific research and publishing
At the inclusion
Expectations regarding artificial intelligence tools in scientific research and publishing
At the inclusion
Study Arms (1)
Authors Survey Group
This label identifies the single cohort of participants, consisting of corresponding authors invited to complete the anonymous online survey. No comparison or control groups are included.
Interventions
This is an observational, non-interventional study based on an anonymous online questionnaire. No intervention is administered to participants.
Eligibility Criteria
The study population consists of corresponding authors who have published scientific articles in leading international medical journals. Participants are identified through publicly available publication data from six major journals (The New England Journal of Medicine, The Lancet, JAMA, Nature, Science, and The BMJ) and are invited to participate via professional email addresses. The population includes adult researchers from diverse biomedical and medical disciplines, with no geographic restriction.
You may qualify if:
- Participants without any disease, condition, or related symptoms are permitted to participate. This study is a non-clinical, observational survey focusing on attitudes and practices related to artificial intelligence in scientific research, not on health conditions.
You may not qualify if:
- Authors who are not corresponding authors.
- Students, residents, interns, or trainees without corresponding author status.
- Individuals not involved in biomedical or medical research activities.
- Individuals who decline to participate or do not complete the online questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de NICE
Nice, Alpes Maritimes, 06000, France
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 24, 2025
First Posted
January 8, 2026
Study Start
December 10, 2025
Primary Completion
March 10, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
January 8, 2026
Record last verified: 2025-12